323 results on '"Tsai, Keng‐Chang"'
Search Results
2. Characterization of anti-EBNA-1 antibodies and exploration of their molecular mimicry potential in an EBV-infected Sjögren's syndrome patient
3. Discovery of oral chemotherapeutic reversal agents for treating multidrug resistance cancer
4. Xin-yi-san contains potent human CYP1A2 inhibitors and its combined use with theophylline in treatment increases adverse risks in patients
5. Ser235 phosphorylation of hepatitis C virus NS5A is required for NS5A dimerization and drug resistance
6. NRICM101 in combatting COVID-19 induced brain fog: Neuroprotective effects and neurovascular integrity preservation in hACE2 mice
7. Northern Groundcone (Boschniakia rossica) and Use in Diabetes via Glucagon-Like Peptide-1
8. Development of anti-aflatoxin B1 nanobodies from a novel mutagenesis-derived synthetic library for traditional Chinese medicine and foods safety testing
9. An auristatin-based antibody-drug conjugate targeting EphA2 in pancreatic cancer treatment
10. Design and synthesis of pyrazole derivatives against neutrophilic inflammation
11. Novel (-)-arctigenin derivatives inhibit signal transducer and activator of transcription 3 phosphorylation and P-glycoprotein function resensitizing multidrug resistant cancer cells in vitro and in vivo
12. Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer
13. Effectiveness of anti-erythropoietin producing Hepatocellular receptor Type-A2 antibody in pancreatic cancer treatment
14. Design, structure–activity relationships, and enzyme kinetic studies of tricyclic and tetracyclic coumarin–based sulfamates as steroid sulfatase inhibitors
15. Pharmacological and mechanistic study of PS1, a Pdia4 inhibitor, in β-cell pathogenesis and diabetes in db/db mice
16. The Design, Structure–Activity, and kinetic studies of 3-Benzyl-5-oxa-1,2,3,4-Tetrahydro-2H-chromeno-(3,4-c)pyridin-8-yl sulfamates as Steroid sulfatase inhibitors
17. A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study
18. Structure-Guided Discovery of PD-1/PD-L1 Interaction Inhibitors: Peptide Design, Screening, and Optimization via Computation-Aided Phage Display Engineering
19. Pdia4 regulates β‐cell pathogenesis in diabetes: molecular mechanism and targeted therapy
20. Ser38‐His93‐Asn91 triad confers resistance of JFH1 HCV NS5A‐Y93H variant to NS5A inhibitors
21. Ser235 phosphorylation of hepatitis C virus NS5A is required for NS5A dimerization and drug resistance
22. Corrigendum to “Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer” [Biochem. Biophys. Res. Commun. 680 (2023) 161–170]
23. Acylguanidine derivatives of zanamivir and oseltamivir: Potential orally available prodrugs against influenza viruses
24. Peramivir conjugates as orally available agents against influenza H275Y mutant
25. Ser38‐His93‐Asn91 triad confers resistance of JFH1 HCV NS5A‐Y93H variant to NS5A inhibitors.
26. NRICM101 ameliorates SARS-CoV-2–S1-induced pulmonary injury in K18-hACE2 mice model
27. The Blockade of Mitogen-Activated Protein Kinase 14 Activation by Marine Natural Product Crassolide Triggers ICD in Tumor Cells and Stimulates Anti-Tumor Immunity
28. Design, Structure–Activity Relationships, And Enzyme Kinetic Studies of Tricyclic and Tetracyclic Coumarin–Based Sulfamates as Steroid Sulfatase Inhibitors
29. Differential inhibition of CYP1-catalyzed regioselective hydroxylation of estradiol by berberine and its oxidative metabolites
30. Additional file 1 of Development of anti-aflatoxin B1 nanobodies from a novel mutagenesis-derived synthetic library for traditional Chinese medicine and foods safety testing
31. Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors
32. Effectiveness of Anti-Erythropoietin Producing Hepatocellular Receptor Type-A2 Antibody in Pancreatic Cancer Treatment
33. Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis
34. Curbing COVID-19 progression and mortality with traditional Chinese medicine among hospitalized patients with COVID-19: A propensity score-matched analysis
35. Tamiphosphor monoesters as effective anti-influenza agents
36. Identification of the perpetrator imperatorin in Xin-yi-san-theophylline interaction: observed and predicted herb-drug interaction in rats.
37. Blockade effect of avian-derived anti-VISTA antibodies on immunosuppressive responses
38. The Design, Structure–Activity, and Kinetic Studies of 3-Benzyl-5-oxa-1,2,3,4-Tetrahydro-2H-chromeno-(3,4-c)pyridin-8-yl Sulfamates as Steroid Sulfatase Inhibitors
39. Pharmacophore-driven identification of human glutaminyl cyclase inhibitors from foods, plants and herbs unveils the bioactive property and potential of Azaleatin in the treatment of Alzheimer's disease
40. A comparison of different electrostatic potentials on prediction accuracy in CoMFA and CoMSIA studies
41. Medicarpin isolated from Radix Hedysari ameliorates brain injury in a murine model of cerebral ischemia
42. Comprehensive Deep Mutational Scanning Reveals the Immune-Escaping Hotspots of SARS-CoV-2 Receptor-Binding Domain Targeting Neutralizing Antibodies
43. Metabolomics study of Buyang Huanwu Tang Decoction in ischemic stroke mice by 1H NMR
44. A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors
45. Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease
46. Generation of avian-derived anti-B7-H4 antibodies exerts a blockade effect on the immunosuppressive response
47. Characterizing the structure–activity relationships of natural products, tanshinones, reveals their mode of action in inhibiting spleen tyrosine kinase
48. Isolation of anti-VEGF monoclonal antibodies with neutralizing effects from an Astragalus-induced immune antibody library
49. Astragalus membranaceus–Derived Anti-Programmed Death-1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors
50. Design and synthesis of 3-benzylaminocoumarin-7-O-sulfamate derivatives as steroid sulfatase inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.